700 related articles for article (PubMed ID: 26319495)
1. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
2. The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis.
Wang XM; Yik WY; Zhang P; Lu W; Dranchak PK; Shibata D; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2012 Oct; 3(5):39. PubMed ID: 23036268
[TBL] [Abstract][Full Text] [Related]
3. Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids.
MacLean GE; Argyriou C; Di Pietro E; Sun X; Birjandian S; Saberian P; Hacia JG; Braverman NE
J Cell Biochem; 2019 Mar; 120(3):3243-3258. PubMed ID: 30362618
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.
Yik WY; Steinberg SJ; Moser AB; Moser HW; Hacia JG
Hum Mutat; 2009 Mar; 30(3):E467-80. PubMed ID: 19105186
[TBL] [Abstract][Full Text] [Related]
5. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum.
Steinberg S; Chen L; Wei L; Moser A; Moser H; Cutting G; Braverman N
Mol Genet Metab; 2004 Nov; 83(3):252-63. PubMed ID: 15542397
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome biogenesis disorders.
Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
[TBL] [Abstract][Full Text] [Related]
7. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance.
Nguyen T; Bjorkman J; Paton BC; Crane DI
J Cell Sci; 2006 Feb; 119(Pt 4):636-45. PubMed ID: 16449325
[TBL] [Abstract][Full Text] [Related]
8. Hypomorphic mutation of PEX3 with peroxisomal mosaicism reveals the oscillating nature of peroxisome biogenesis coupled with differential metabolic activities.
Takashima S; Fujita H; Toyoshi K; Ohba A; Hirata Y; Shimozawa N; Oh-Hashi K
Mol Genet Metab; 2022; 137(1-2):68-80. PubMed ID: 35932552
[TBL] [Abstract][Full Text] [Related]
9. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y
Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004
[TBL] [Abstract][Full Text] [Related]
10. Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1.
Demaret T; Courtoy GE; Ravau J; Van Der Smissen P; Najimi M; Sokal EM
Histochem Cell Biol; 2020 May; 153(5):295-306. PubMed ID: 32124009
[TBL] [Abstract][Full Text] [Related]
11. A newly identified mutation in the
Tanaka AJ; Okumoto K; Tamura S; Abe Y; Hirsch Y; Deng L; Ekstein J; Chung WK; Fujiki Y
Cold Spring Harb Mol Case Stud; 2019 Feb; 5(1):. PubMed ID: 30446579
[TBL] [Abstract][Full Text] [Related]
12. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.
Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ
Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136
[TBL] [Abstract][Full Text] [Related]
13. A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.
Steinberg SJ; Snowden A; Braverman NE; Chen L; Watkins PA; Clayton PT; Setchell KD; Heubi JE; Raymond GV; Moser AB; Moser HW
J Inherit Metab Dis; 2009 Feb; 32(1):109-19. PubMed ID: 19127411
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
[TBL] [Abstract][Full Text] [Related]
15. Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics.
Liang JS; Hung KL; Lin LJ; Ong WP; Keng WT; Lu JF
Epilepsy Behav; 2023 Aug; 145():109266. PubMed ID: 37385119
[TBL] [Abstract][Full Text] [Related]
16. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.
Berendse K; Boek M; Gijbels M; Van der Wel NN; Klouwer FC; van den Bergh-Weerman MA; Shinde AB; Ofman R; Poll-The BT; Houten SM; Baes M; Wanders RJA; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2774-2787. PubMed ID: 31207289
[TBL] [Abstract][Full Text] [Related]
17. A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders.
Mast FD; Li J; Virk MK; Hughes SC; Simmonds AJ; Rachubinski RA
Dis Model Mech; 2011 Sep; 4(5):659-72. PubMed ID: 21669930
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
Krause C; Rosewich H; Woehler A; Gärtner J
Hum Mol Genet; 2013 Oct; 22(19):3844-57. PubMed ID: 23716570
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.
Herzog K; Pras-Raves ML; Vervaart MA; Luyf AC; van Kampen AH; Wanders RJ; Waterham HR; Vaz FM
J Lipid Res; 2016 Aug; 57(8):1447-54. PubMed ID: 27284103
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
